CDEK
← All organizations

Cidara Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Cidara Therapeutics Inc. | CIDARA THERAPS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2015

First marketed drug

Mar 22, 2023

First NDA

Mar 22, 2023

Last known activity

Nov 8, 2025

Acquired by Merck on Nov 19, 2025

Timeline

2010s

  1. Jun 1, 2012

    Cidara Therapeutics— Founded

2020s

  1. Mar 22, 2023

    rezafungin— Marketing Organization

  2. Mar 22, 2023

    rezafungin— NDA Organization

  3. Mar 22, 2023

    rezafungin— NDA Secondary Org

  4. Nov 19, 2025

    Merck— Acquired By

Drugs by trial phase (9 distinct, 13 trials)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (24)

Details

Founded
San Diego, CA, US Jun 1, 2012
First NDA
Mar 22, 2023
Last known activity
Nov 8, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review